Additionally, to investigate Bortezomib’s effect on TRIM44 expression levels, we treated MM cell lines with varying doses of Bortezomib for 24 h and conducted immunoblot analyses to measure TRIM44 protein levels. Here, TRIM44 is linked to Miyoshi myopathy.